Health Care
Holding(s) in Company | 20-Nov-2024 | 12:41 | RNS |
CMS Topical Oxygen Therapy coverage review | 11-Nov-2024 | 07:00 | RNS |
2024 Interim Results | 16-Sep-2024 | 07:00 | RNS |
Pre-close Trading Update | 15-Aug-2024 | 07:00 | RNS |
US FDA 510(k) Clearance of NEXATM NPWT System | 29-Jul-2024 | 07:00 | RNS |
Holding(s) in Company | 21-Jun-2024 | 14:45 | RNS |
Holding(s) in Company | 21-Jun-2024 | 13:41 | RNS |
Admission to AIM and First Day of Dealings | 18-Jun-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 129.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 136.00p |
52 Week Low | 126.00p |
Volume | 0 |
Shares Issued | 106.36m |
Market Cap | £137.20m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CEO | Michael Stephen Griffiths |
COO | Anthony Matthew Moffatt |
CFO | Jayesh Pankhania |
You are here: research